Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
West China Journal of Stomatology ; (6): 395-404, 2023.
Article in English | WPRIM | ID: wpr-1007920

ABSTRACT

OBJECTIVES@#This study aims to investigate the effects and mechanisms of chondroitin sulfate (CS), dermatan sulfate (DS), and heparin (HEP) on chondrogenesis of murine chondrogenic cell line (ATDC5) cells and the maintenance of murine articular cartilage in vitro.@*METHODS@#ATDC5 and articular cartilage tissue explant were cultured in the medium containing different sulfated glycosaminoglycans. Cell proliferation, differentiation, cartilage formation, and mechanism were observed using cell proliferation assay, Alcian blue staining, real-time quantitative polymerase chain reaction (RT-qPCR), and Western blot, respectively.@*RESULTS@#Results showed that HEP and DS primarily activated the bone morphogenetic protein (BMP) signal pathway, while CS primarily activated the protein kinase B (AKT) signal pathway, further promoted ATDC5 cell proliferation and matrix production, and increased Sox9, Col2a1, and Aggrecan expression.@*CONCLUSIONS@#This study investigated the differences and mechanisms of different sulfated glycosaminoglycans in chondrogenesis and cartilage homeostasis maintenance. HEP promotes cartilage formation and maintains the normal state of cartilage tissue in vitro, while CS plays a more effective role in the regeneration of damaged cartilage tissue.


Subject(s)
Animals , Mice , Cartilage/metabolism , Cell Differentiation , Cells, Cultured , Chondrocytes/metabolism , Chondrogenesis/physiology , Glycosaminoglycans/pharmacology
2.
Invest. clín ; 51(4): 467-477, dic. 2010. ilus
Article in Spanish | LILACS | ID: lil-630905

ABSTRACT

La disfunción endotelial (DE) se presenta en pacientes con hipercolesterolemia, hipertensión arterial, obesidad y diabetes mellitus. Evidencias sugieren un papel de los glicosaminoglicanos en la DE. Evaluamos el efecto del sulodexide (SLD), un glicosaminoglicano utilizado en el tratamiento de la albuminuria y la enfermedad isquémica en pacientes diabéticos, sobre la relajación arterial y los cambios morfológicos en un modelo experimental de diabetes tipo 1. La diabetes se indujo a ratas Sprague Dawley administrando estreptozotocina (STZ), 60 mg/kg, i.v. Los animales fueron distribuidos en los siguientes grupos: I= control, II= diabéticas, III: control + sulodexide, IV= diabéticas + sulodexide (15 mg/kg/día s.c). A los 3 meses fueron sacrificados, las aortas extraídas para evaluar la relajación vascular inducida por acetilcolina (Ach) y nitroprusiato de sodio en anillos precontraídos con fenilefrina. Fueron evaluadas histológicamente mediante microscopía de luz y coloraciones diversas. El SLD in vitro no modificó la tensión basal de los anillos arteriales en reposo o precontraídos con fenilefrina. La diabetes disminuyó la capacidad de relajación arterial en respuesta a la Ach en un 28,8-35,1% vs control, efecto que fue prevenido por SLD. No se observó diferencia significativa en la relajación inducida por nitroprusiato sódico entre los grupos. El estudio histológico en los animales diabéticos mostró alteraciones estructurales, particularmente en la íntima y la adventicia, cambios que fueron prevenidos por el tratamiento con SLD. Nuestros resultados apoyan la potencial utilidad terapéutica del SLD en el tratamiento de la disfunción endotelial.


Endothelial dysfunction (ED) is observed in patients with hypercholesterolemia, arterial hypertension, obesity and diabetes mellitus. Recent evidences suggest the involvement of glycosaminoglycans(GSG) in ED. We evaluated the effect of sulodexide (SLD), a natural GSG used in albuminuria and ischemic diabetes treatment, on arterial relaxation and vascular morphological changes in a diabetic type I model. Diabetes was induced, in Sprague-Dawley rats by streptozotocine (STZ) administration, 60 mg, iv. Rats were divided into four groups; I: control, II: diabetics, III: control + SLD, IV: diabetics treated with SLD (15 mg/day). After three months, phenylephrine precontracted aortic rings were used to evaluate acetylcholine (ACh) and sodium nitroprusside (NPS) relaxation capacities. Light microscopy of aorta was done with several staining procedures. In vitro, SLD did not change smooth muscle tone in resting or phenylephrine precontracted aortic rings. In diabetic rats, ACh relaxation was 28.8-35.1% lower than in control rats. Diabetic rats treated with SLD showed aortic ACh relaxation similar to control rats. No significative statistical difference was found in endothelium-independent NPS relaxation, between the different groups. Light microscopy histological studies revealed important morphological alterations, particularly in intima and adventitia layers of aortic artery; those changes were dramatically reversed in SLD treated rats. Our experiments support the conclusion that SLD is a potential drug for improving endothelial dysfunction in diabetes.


Subject(s)
Animals , Male , Rats , Aorta/drug effects , Aortic Diseases/prevention & control , Diabetes Mellitus, Experimental/drug therapy , Diabetic Angiopathies/prevention & control , Endothelium, Vascular/drug effects , Glycosaminoglycans/therapeutic use , Hypoglycemic Agents/therapeutic use , Vasodilation/drug effects , Acetylcholine/pharmacology , Aorta/pathology , Aorta/physiopathology , Aortic Diseases/etiology , Aortic Diseases/pathology , Aortic Diseases/physiopathology , Drug Evaluation, Preclinical , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Experimental/physiopathology , Diabetic Angiopathies/etiology , Diabetic Angiopathies/pathology , Diabetic Angiopathies/physiopathology , Endothelium, Vascular/ultrastructure , Glycosaminoglycans/metabolism , Glycosaminoglycans/pharmacology , Hypoglycemic Agents/pharmacology , Nitroprusside/pharmacology , Rats, Sprague-Dawley , Tunica Intima/drug effects , Tunica Intima/ultrastructure
3.
Braz. j. med. biol. res ; 34(6): 699-709, Jun. 2001. ilus, tab, graf
Article in English | LILACS | ID: lil-285842

ABSTRACT

The anticlotting and antithrombotic activities of heparin, heparan sulfate, low molecular weight heparins, heparin and heparin-like compounds from various sources used in clinical practice or under development are briefly reviewed. Heparin isolated from shrimp mimics the pharmacological activities of low molecular weight heparins. A heparan sulfate from Artemia franciscana and a dermatan sulfate from tuna fish show a potent heparin cofactor II activity. A heparan sulfate derived from bovine pancreas has a potent antithrombotic activity in an arterial and venous thrombosis model with a negligible activity upon the serine proteases of the coagulation cascade. It is suggested that the antithrombotic activity of heparin and other antithrombotic agents is due at least in part to their action on endothelial cells stimulating the synthesis of an antithrombotic heparan sulfate.


Subject(s)
Humans , Animals , Cattle , Anticoagulants/pharmacology , Endothelium, Vascular/cytology , Fibrinolytic Agents/pharmacology , Heparin/pharmacology , Heparitin Sulfate/pharmacology , Anticoagulants/chemistry , Anticoagulants/metabolism , Crustacea , Fibrinolytic Agents/chemistry , Fibrinolytic Agents/metabolism , Glycosaminoglycans/metabolism , Glycosaminoglycans/pharmacology , Heparin, Low-Molecular-Weight/chemistry , Heparin, Low-Molecular-Weight/metabolism , Heparin, Low-Molecular-Weight/pharmacology , Heparin/metabolism , Heparitin Sulfate/biosynthesis , Tuna
6.
Rev. Assoc. Paul. Cir. Dent ; 40(3): 254-6, 258-60, maio-jun. 1986. ilus
Article in Portuguese | LILACS | ID: lil-35202

ABSTRACT

O presente trabalho teve como uma de suas finalidades, acompanhar a síntese de colágeno e glicosaminoglicans (mucopolissacarídeos ácidos) no tecido de granulaçäo, induzido artificialmente em ratos, desde uma fase precoce até sua maturaçäo. Por outro lado, objetivou-se estudar os efeitos de drogas antiinflamatórias, com princípios ativos diferentes, na evoluçäo deste mesmo tecido, comparando-a com aquela observada em animais sob condiçöes normais. Os resultados obtidos, de acordo com as doses empregadas, demonstraram que a dexametasona 21-fosfato é uma potente inibidora da síntese de mucopolissacarídeos ácidos e de colágeno, o mesmo acontecendo com a fenilbutazona, esta, porém, inibindo tal síntese em menor grau. Paralelamente, a tripsina pareceu interferir na proliferaçäo do tecido de granulaçäo de uma maneira positiva, quantitativa como qualitativamente. A partir desses resultados, pode-se concluir que o corticosteróide sintético (dexametasona 21-fosfato), assim como a fenilbutazona, nas doses administradas, constituem-se em grandes recursos terapêuticos quando houver necessidade de uma inibiçäo da proliferaçäo do tecido de granulaçäo. Ao contrário, o antiinflamatório de origem enzimática (tripsina) estaria indicado em processos inflamatórios nos quais uma síntese mais rápida e organizada do tecido de granulaçäo for de primordial importância


Subject(s)
Rats , Animals , Dexamethasone/pharmacology , Glycosaminoglycans/pharmacology , Granulation Tissue/drug effects , Phenylbutazone/pharmacology , Trypsin/pharmacology , Granulation Tissue/pathology
SELECTION OF CITATIONS
SEARCH DETAIL